Type 1 diabetes mellitus, presymptomatic, unspecified

This code describes an individual who has not yet developed overt symptoms of type 1 diabetes but exhibits serological evidence of autoimmune destruction of pancreatic beta cells, indicating an early, asymptomatic stage of the disease. It signifies a high risk for progression to clinical type 1 diabetes.

Use this code for patients identified through screening (e.g., family history, research studies) who test positive for two or more diabetes-related autoantibodies (e.g., GAD65, ICA, IAA, IA-2A) but maintain normal glucose tolerance. Documentation should clearly state "presymptomatic type 1 diabetes" or "stage 1 type 1 diabetes" with supporting lab results.

• Do not use this code if the patient has any symptoms of hyperglycemia or abnormal glucose tolerance; instead, consider codes for established type 1 diabetes.
• This code is distinct from "latent autoimmune diabetes in adults" (LADA), which typically presents later in life with a slower progression.
• Ensure documentation specifies "unspecified" if the specific autoantibodies or other details of the presymptomatic stage are not fully documented.